Cited by 22Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Risk factors associated with early postpartum glucose intolerance in women with a history of gestational diabetes mellitus: a systematic review and meta-analysis

Liu, Zhe, Zhang, Qianghuizi, Liu, Leyang, Liu, Weiwei·2023·Endocrine

Abstract

Purpose This meta-analysis was aimed at exploring the incidence and risk factors of glucose intolerance in women with gestational diabetes mellitus (GDM) at 6-12 weeks postpartum to inform the development of preventive strategies. Method We searched Pubmed, Embase, Web of Science, the Cochrane Library, Ovid, China Knowledge Resource Integrated Database (CNKI), Wanfang Database and China Biology Medicine Database for entries between January 1990 and September 2022. The search terms included gestational diabetes mellitus, postpartum, glucose intolerance and type 2 diabetes. The meta-analysis was conducted using Stata 14.0. Result We included 37 studies, with 21 and 16 having low and medium risk of bias, respectively. The incidence of glucose intolerance in women with GDM 6-12 weeks postpartum was 27% (95% CI: 0.22-0.33). The following risk factors for GDM 6-12 weeks postpartum were identified: insulin use during pregnancy (OR = 3.23; 95% CI: 2.35-4.44), family history of diabetes (OR = 2.94; 95% CI: 1.98-4.33), abnormal fasting glucose levels at 24-28 weeks of gestation (OR = 1.15; 95% CI: 1.07-1.25), high pre-pregnancy BMI (OR = 1.63; 95% CI: 1.23-2.15), abnormal triglyceride levels during 28-40 weeks of gestation (OR = 2.18; 95% CI: 1.18-4.03), abnormal HbA 1 c levels at 28-40 weeks of gestation (OR = 6.62; 95% CI: 4.71-9.30), history of previous GDM (OR = 2.11; 95% CI: 1.27-3.49), and high 1-h glucose levels at 24-28 weeks of gestation (OR = 1.16; 95% CI:1.06-1.28). Conclusi…

Integrity signals

Registry

Crossref · 10.1007/s12020-023-03472-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GDM is often indicative of underlying beta-cell dysfunction, which confers marked increased risk for later development of glucose intolerance and diabetes in the mother after delivery.

    “GDM is often indicative of underlying b-cell dysfunction (182), which confers marked increased risk for later development of glucose intolerance and diabetes in the mother after delivery (183-185).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liu, Z., Zhang, Q., Liu, L., & Liu, W.
Affiliations
Capital Medical University (CN)
Corresponding author
Liu, Weiwei
Venue
Endocrine
Published
2023-08-16
Volume
82
Issue
3
Pages
498-512
ISSN
  • 0969-711X (ISSN-L)
  • 1559-0100
OpenAlex
W4385858190
Cited by
22
References
5
Citations by year
2026: 10 · 2025: 5 · 2024: 6 · 2023: 1
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (71904133)
  • Medjaden Academy & Research Foundation for Young Scientists (No. MJA202306038)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, postpartum glucose intolerance, type 2 diabetes risk, risk factors, family history of diabetes, pre-pregnancy body mass index, triglycerides, HbA1c, fasting blood glucose, incidence, prevention, women's health, pregnancy outcomes, postpartum period, glycemic control in pregnancy, postpartum follow-up
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Pregnancy, Risk Factors, Diabetes, Gestational, Glucose Intolerance, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review